Search

everythinglearnresearchcommunity

for

Search:↓

Adding anti-Müllerian hormone to PCOS criteria lowers the number of women diagnosed.

Hormone therapy for trans individuals is effective and generally safe in the short term.

New treatments for male hypogonadism are effective and should be personalized.

Metabolic syndrome and PCOS are related but separate conditions, with metabolic syndrome increasing the risk of heart disease and diabetes.

Insulin resistance contributes to hormone imbalances in many women with polycystic ovary syndrome.

Obese women with PCOS are more likely to have fatty liver disease.

Obese people have more skin problems like stretch marks and infections, which get worse with higher obesity levels.

Certain genetic variations in the SHBG gene are linked to an increased or decreased risk of PCOS in Mediterranean women.

About 8.5% of women in Salvador, Brazil, have Polycystic Ovary Syndrome.

Female hair loss linked to metabolic syndrome, not in males.

Shorter CAG repeats in a specific gene may increase male hormone activity and symptoms like acne and excess hair in women with PCOS.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Women with PCOS have higher xanthine oxidase activity linked to inflammation and heart disease risks.

The Random Forest algorithm was the most accurate at diagnosing Polycystic Ovarian Syndrome.

Isotretinoin improves severe acne without changing androgen or insulin levels but may increase body weight and triglycerides.

A combined drug and laser treatment improved hirsutism in a PCOS patient, also enhancing her heart health and requiring regular liver and kidney checks.

Metabolic syndrome in kids and teens is linked to obesity and increases diabetes and heart disease risk; early lifestyle changes are crucial for management.

The document suggests that there might be an autoimmune link between polycystic ovary syndrome and Graves' disease.

Changing the diagnosis criteria for PCOS might miss women at risk for related health issues.

Topical minoxidil is the most promising treatment for male pattern hair loss, but more research is needed to confirm its effectiveness and safety.

Normal-range ALT levels can indicate metabolic and hormonal imbalances in young women.

AGA risk factors include age, smoking, hypertension for men, and age, dyslipidemia for women; lifestyle changes may help prevention.

Balding and low testosterone increase risk of urinary stones.

Eating cream can increase ovarian androgen production in women with Polycystic Ovary Syndrome, which is not related to obesity.

Hair loss in women linked to higher sexual dysfunction risk.

Indian women with PCOS may need different ultrasound criteria for diagnosis than current standards.

Treating PCOS is complex, involving medication like metformin and lifestyle changes, and requires attention to mental health due to high depression and anxiety rates.

Imiquimod improved skin pigmentation in most patients with xeroderma pigmentosum and may prevent further skin cancer, but some treatments can have side effects.

PCOS and related metabolic issues often run in families.

Early-onset AGA shows different hair and metabolic characteristics compared to normal-onset AGA.